The holiday season is perhaps the busiest time of year for the retail sector. Between Black Friday, Cyber Monday and many well-timed new product launches, we can assume that the supply chain is working overtime.
Supply Chain
Bob Kocher, MD, and Bryan Roberts are partners at the venture capital firm Venrock, where they specialize in healthcare-related investment opportunities. In an article for Fortune, Dr. Kocher and Mr. Roberts share 10 healthcare predictions for 2017.
Clovis Oncology on Monday earned accelerated approval from the Food and Drug Administration for its ovarian cancer drug Rubracam, reports Reuters.
The U.K.'s National Institute for Health and Care Excellence will join the Food and Drug Administration's Payer Communication Task Force to help more medical devices, diagnostics and other health-related technologies reach the market faster, reports RAPS.
Mondher Mahjoubi will leave his role as head of AstraZeneca's oncology division to serve as the new CEO of Innate Pharma, a French biotech focusing on immuno-oncology therapies, reports Reuters.
Advertisement
Amazon may be developing — or looking to acquire — a mobile technology to link available trucks with shipments needing to be transported, reports The Wall Street Journal.
As drug prices continue to rise, many U.S. hospitals are implementing aggressive strategies to reduce pharmaceutical spending, reports The Wall Street Journal.
The Food and Drug Administration will allow Pfizer to remove a serious warning from the label of its anti-smoking drug Chantix, reports Fox News.
Actavis could face fines for raising the price of its steroid treatment by more than 12,000 percent, reports Bloomberg.
Companies must untangle a complex web of factors when deciding not only where to locate a distribution center, but also how to run it, reports DC Velocity.